California Clinical Trials (CCT) is the world leader in Japanese Bridging Studies. We help major drug companies gather their Japanese data right here in the U.S., saving time and development costs. Sogo-Kikho, the Japanese equivalent of the FDA, recognizes data gathered by CCT as acceptable to their approval guidelines, and has recently collaborated with CCT staff to create protocols for all Japanese studies done outside of Japan. No other research center outside of Japan, even Hawaii, has access to such a large number of qualified Japanese volunteers as CCT. The result has been the establishment of a highly specialized definition of qualified Japanese volunteers that may participate in a Japanese bridging study.

CCT scientists literally wrote the book on Japanese Bridging studies, . “Ethnicity in Drug Development and Therapeutics”. This comprehensive book, covers current scientific, regulatory, and research issues